Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The Effects of “Fangcang, Huoshenshan, and Leishenshan” Hospitals and Temperature on the Mortality of COVID-19

Yuwen Cai, Tianlun Huang, Xin Liu, Gaosi Xu
doi: https://doi.org/10.1101/2020.02.26.20028472
Yuwen Cai
aDepartment of Nephrology, the Second Affiliated Hospital of Nanchang University, China
bGrade 2016, the Second Clinical Medical College of Nanchang University, Jiangxi, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tianlun Huang
aDepartment of Nephrology, the Second Affiliated Hospital of Nanchang University, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xin Liu
aDepartment of Nephrology, the Second Affiliated Hospital of Nanchang University, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gaosi Xu
aDepartment of Nephrology, the Second Affiliated Hospital of Nanchang University, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gaosixu@163.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background In December 2019, a novel coronavirus disease (COVID-19) broke out in Wuhan, China, however, the factors affecting the mortality remain unclear.

Methods Thirty-two days of data that were shared by China National Health Commission and China Weather Net were collected using standard forms. The difference in the mortality of confirmed and severe cases before and after the use of “Fangcang, Huoshenshan, and Leishenshan” makeshift hospitals (MSHs) was tested using Mann-Whitney U test. We also studied whether air temperature (AT) could affect the above outcomes of COVID-19 cases by performing Spearman’s analysis.

Results Eight days after the use of MSHs, the mortality of confirmed cases was significantly decreased both in Wuhan (U = 1, P < 0.001) and Hubei (U = 0, P < 0.001), while in non-Hubei regions, as a contrast, the mortality of confirmed cases remained unchanged (U = 40, P = 0.139). However, another eight days later, changes in the mortality in non-Hubei regions also became significant (U = 73, P = 0.039). Mortality of confirmed cases was found to be significantly correlated with AT both in Wuhan (r = −0.441, P = 0.012) and Hubei (r = −0.440, P = 0.012).

Conclusions Our findings indicated that both the use of MSHs and the rise of AT were beneficial to the survival of COVID-19 cases.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

1. National Natural Science Foundation of China (No. 81970583) 2. Nature Science Foundation of Jiangxi Province (No. 20181BAB205016)

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

1. National Health Commission of the people's Republic of China (http://www.nhc.gov.cn/) 2. China Weather Net (http://www.weather.com.cn/)

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 06, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The Effects of “Fangcang, Huoshenshan, and Leishenshan” Hospitals and Temperature on the Mortality of COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The Effects of “Fangcang, Huoshenshan, and Leishenshan” Hospitals and Temperature on the Mortality of COVID-19
Yuwen Cai, Tianlun Huang, Xin Liu, Gaosi Xu
medRxiv 2020.02.26.20028472; doi: https://doi.org/10.1101/2020.02.26.20028472
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The Effects of “Fangcang, Huoshenshan, and Leishenshan” Hospitals and Temperature on the Mortality of COVID-19
Yuwen Cai, Tianlun Huang, Xin Liu, Gaosi Xu
medRxiv 2020.02.26.20028472; doi: https://doi.org/10.1101/2020.02.26.20028472

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (135)
  • Cardiovascular Medicine (1748)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (654)
  • Epidemiology (10785)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2935)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1919)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12501)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (322)
  • Neurology (2784)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (556)
  • Occupational and Environmental Health (597)
  • Oncology (1458)
  • Ophthalmology (441)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (334)
  • Psychiatry and Clinical Psychology (2633)
  • Public and Global Health (5342)
  • Radiology and Imaging (1004)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (724)
  • Rheumatology (329)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)